180 related articles for article (PubMed ID: 31226475)
1. Coated nanostructured lipid carriers targeting the joints - An effective and safe approach for the oral management of rheumatoid arthritis.
Zewail M; Nafee N; Helmy MW; Boraie N
Int J Pharm; 2019 Aug; 567():118447. PubMed ID: 31226475
[TBL] [Abstract][Full Text] [Related]
2. Synergistic and receptor-mediated targeting of arthritic joints via intra-articular injectable smart hydrogels containing leflunomide-loaded lipid nanocarriers.
Zewail M; Nafee N; Helmy MW; Boraie N
Drug Deliv Transl Res; 2021 Dec; 11(6):2496-2519. PubMed ID: 34013458
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
Noor NM; Sheikh K; Somavarapu S; Taylor KMG
Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
[TBL] [Abstract][Full Text] [Related]
4. Intra-Articular Dual Drug Delivery for Synergistic Rheumatoid Arthritis Treatment.
Zewail M; Nafee N; Boraie N
J Pharm Sci; 2021 Jul; 110(7):2808-2822. PubMed ID: 33848528
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid coated teriflunomide (A771726) loaded lipid carriers for the oral management of rheumatoid arthritis.
Zewail M; El-Deeb NM; Mousa MR; Abbas H
Int J Pharm; 2022 Jul; 623():121939. PubMed ID: 35724825
[TBL] [Abstract][Full Text] [Related]
6. Chitosan coated nanostructured lipid carriers for enhanced in vivo efficacy of albendazole against Trichinella spiralis.
Eid RK; Ashour DS; Essa EA; El Maghraby GM; Arafa MF
Carbohydr Polym; 2020 Mar; 232():115826. PubMed ID: 31952620
[TBL] [Abstract][Full Text] [Related]
7. Folic acid decorated chitosan-coated solid lipid nanoparticles for the oral treatment of rheumatoid arthritis.
Zewail M
Ther Deliv; 2021 Apr; 12(4):297-310. PubMed ID: 33726498
[No Abstract] [Full Text] [Related]
8. Transdermal drug delivery of triptolide-loaded nanostructured lipid carriers: Preparation, pharmacokinetic, and evaluation for rheumatoid arthritis.
Gu Y; Tang X; Yang M; Yang D; Liu J
Int J Pharm; 2019 Jan; 554():235-244. PubMed ID: 30423415
[TBL] [Abstract][Full Text] [Related]
9. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
Li H; Chen M; Su Z; Sun M; Ping Q
Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
[TBL] [Abstract][Full Text] [Related]
10. Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular.
Li J; Tan G; Cheng B; Liu D; Pan W
Eur J Pharm Biopharm; 2017 Nov; 120():89-97. PubMed ID: 28867370
[TBL] [Abstract][Full Text] [Related]
11. Chitosan coated clove oil-based nanoemulsion: An attractive option for oral delivery of leflunomide in rheumatoid arthritis.
Zewail MB; El-Gizawy SA; Asaad GF; Shabana ME; El-Dakroury WA
Int J Pharm; 2023 Aug; 643():123224. PubMed ID: 37451327
[TBL] [Abstract][Full Text] [Related]
12. Folate decorated chitosan-chondroitin sulfate nanoparticles loaded hydrogel for targeting macrophages against rheumatoid arthritis.
Siddiqui B; Ur Rehman A; Gul R; Chaudhery I; Shah KU; Ahmed N
Carbohydr Polym; 2024 Mar; 327():121683. PubMed ID: 38171692
[TBL] [Abstract][Full Text] [Related]
13. The role of chitosan as coating material for nanostructured lipid carriers for skin delivery of fucoxanthin.
Malgarim Cordenonsi L; Faccendini A; Catanzaro M; Bonferoni MC; Rossi S; Malavasi L; Platcheck Raffin R; Scherman Schapoval EE; Lanni C; Sandri G; Ferrari F
Int J Pharm; 2019 Aug; 567():118487. PubMed ID: 31271813
[TBL] [Abstract][Full Text] [Related]
14. Daidzein-loaded nanostructured lipid carriers-PLGA nanofibers for transdermal delivery.
Song J; Fan X; Shen Q
Int J Pharm; 2016 Mar; 501(1-2):245-52. PubMed ID: 26851353
[TBL] [Abstract][Full Text] [Related]
15. G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol.
Qi R; Li YZ; Chen C; Cao YN; Yu MM; Xu L; He B; Jie X; Shen WW; Wang YN; van Dongen MA; Liu GQ; Banaszak Holl MM; Zhang Q; Ke X
J Control Release; 2015 Jul; 210():160-8. PubMed ID: 26003044
[TBL] [Abstract][Full Text] [Related]
16. Anti-arthritic effect of β-caryophyllene and its ameliorative role on methotrexate and/or leflunomide-induced side effects in arthritic rats.
El-Sheikh SMA; Abd El-Alim AEF; Galal AAA; El-Sayed RG; El-Naseery NI
Life Sci; 2019 Sep; 233():116750. PubMed ID: 31408659
[TBL] [Abstract][Full Text] [Related]
17. Chitosan-coated nanostructured lipid carriers for effective brain delivery of Tanshinone IIA in Parkinson's disease: interplay between nuclear factor-kappa β and cathepsin B.
Hassan DM; El-Kamel AH; Allam EA; Bakr BA; Ashour AA
Drug Deliv Transl Res; 2024 Feb; 14(2):400-417. PubMed ID: 37598133
[TBL] [Abstract][Full Text] [Related]
18. Comparison of different aliphatic acid grafted N-trimethyl chitosan surface-modified nanostructured lipid carriers for improved oral kaempferol delivery.
Du Q; Chen J; Yan G; Lyu F; Huang J; Ren J; Di L
Int J Pharm; 2019 Sep; 568():118506. PubMed ID: 31302169
[TBL] [Abstract][Full Text] [Related]
19. Transdermal delivery system of nanostructured lipid carriers loaded with Celastrol and Indomethacin: optimization, characterization and efficacy evaluation for rheumatoid arthritis.
Kang Q; Liu J; Zhao Y; Liu X; Liu XY; Wang YJ; Mo NL; Wu Q
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S585-S597. PubMed ID: 30306802
[TBL] [Abstract][Full Text] [Related]
20. Mucoadhesive nanostructured lipid carriers (NLCs) as potential carriers for improving oral delivery of curcumin.
Chanburee S; Tiyaboonchai W
Drug Dev Ind Pharm; 2017 Mar; 43(3):432-440. PubMed ID: 27808665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
